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Conclusions: PCR and DNA sequencing detected the
presence of H. hepaticus more often in liver biopsies with
HCV infection without than with concomitant HCC.
OL-049 Screening of proteins binding to HCV NS3
protein from human pancreas cDNA library by
yeast two-hybrid
C.C. Hu, J.Q. Zhang*, X.C. Wang, G.L. Li, Q. Wang,
J. Cheng. Institute of Infectious Diseases, Beijing Ditan
Hospital, Beijing 100011, China
Objective: To screen proteins of human pancreas cDNA
library interacting with HCV NS3 protein.
Methods: The library was amplifed, puriﬁed and evaluated,
and then the puried library plasmids were transformed
into yeast strain Y187. The reconstructed plasmid pGBKT7-
NS3 was transformed into yeast strain AH109 and
screened on the nutrient deﬁciency medium SD/-Trp.
The transformed AH109 mated with Y187 containing the
library plasmid. The diploid yeast cells were plated on
nutrient deﬁciency medium SD/-Trp/-Leu/-His/-Ade and
SD/-Trp/-Leu/-His/-Ade containing X-a-gal for selecting.
The plasmids in diploid yeast cells were extracted and
electrotransformed into E. coli DH5a. The plasmids in DH5a
were extracted, sequenced and analyzed by bioinformatic
methods.
Results: Eight proteins interacting with HCV NS3 were
found.
Conclusions: These results show that HCV NS3 protein may
be related with metabolism of glucose and lipid.
Supported by the National Natural Science Foundation of
China, No. 30600524.
OL-050 Extended Programme of Immunization (E.P.I) in
Pakistan; shadow shift from polio to hepatitis,
the threatening upcoming challenge
T. Hussain1 *, R. Ara2. 1Department of Cardiology, Union
Hospital, International Students/Doctors Building, Tongji
Medical College, Wuhan, China, 2Department of Law,
Islamabad, Pakistan
Background and Aims: In past, EPI-Pakistan focused primar-
ily on diseases like Polio/Measles/Mumps/Tuberculosis, but
as ﬁgures switched from 238 Polio, 0.3 Million Hepatitis-B
and nearly 0.45 Million Hepatitis-C registered cases in
1997 to 30 Polio, 5.3 Million Hepatitis-B and 4.9 Million
Hepatitis-C cases in 2007, government changed the policy,
making a stress over Hepatitis-B control.
HBV/HCV is well known to cause hepatitis/related
complications throughout the world, proving a threatening
challenge to developing countries. Study aim was to
estimate seropositivity levels of HBV/HCV among apparently
healthy young population.
Methods: Study was conducted at Holy-Family Hospital
Rawalpindi, Pakistan. Over a period of 6months, 500cases
aged between 20 40Years including 50Doctors and 450
routine blood-donors were screened after written-informed
consent. They had neither any sign nor symptom of
acute/chronic liver-disease. Samples were screened for
HBsAg and Anti-HCV-antibodies. Cases found positive for
HCV-Ab were interviewed for possible risk factors.
Results: Overall 52% were male, 6.4% positive for HBsAg,
male-female ratio 38:27, mean-age 24±4 years, 4.7%
positive for Anti-HCV-antibodies, mean-age 25±3 years and
0.33% positive for both. Overall infection-rate was 3.3%.
Prevalence-rate of Anti-HCV-antibodies (4.7%) was less than
HBsAg positivity (6.4%). There was no signiﬁcant overlap
(0.5%) between seropositivity of Anti-HCV with HBsAg,
reﬂecting different epidemiological-factors. Cases with
Anti-HCV antibodies were further evaluated; 56% were with
raised ALT, 79% had risk factors including blood-group testing
(71%), parenteral-medications/needle/prick-injuries (71%),
dental-procedures (19%), previous-surgery/tattoo-markings
(15%), unsafe-sex (19%) and multiple blood-transfusions
(2%). 7% gave no history of possible exposure. 16 doctors
positive for virus (14Hep-B and 2Hep-C), all gave history of
needle-prick injuries.
Conclusion: Hepatitis B-Vaccine inclusion in EPI-Pakistan
will decline its prevalence but HCV mostly spread via
health-care facilities, so behavior-modiﬁcation is superior
to clinical therapy as minimizing all types of needle-pricks
is advised till proper aseptic practice.
Acknowledgement: Dr. Abbas Hayat, Dr. Sara Tajammul, Dr.
Aamra Sartaj and Ali Mumtaz.
OL-051 Detect the gene expression inﬂuence after the
interaction between HCV NS4A and CAML with
microarray assay
Y.Q. Cheng*, Y. Liu, L. Wang, J. Cheng, D.P. Xu, Y.W. Zhong,
J.Z. Dai, X.D. Li. The 302 Hospital of PLA, Beijing 100039,
China
Aim: To understand gene expression inﬂuence after the
interaction between HCV NS4A and CAML.
Methods: The expressive vector of pCMV/Myc-NS4A
and pcDNA3.1/HisA-CAML were constructed by routine
molecular biological methods. The 293 cells were
transfected by pCMV/Myc-NS4A and pcDNA3.1/HisA-CAML,
respectively using lipofectamine. The total RNAwas isolated
and reverse transcribed. The cDNAs were subjected for
microarray screening.
Results: The expressive vector has been constructed
and conﬁrmed by restriction enzyme digestion and DNA
sequencing analysis. The expression of CAML protein has
been conﬁrmed by Western blot with single chain variable
region (scFv) antibody. High quality mRNA and cDNA had
been prepared and successful microarray screening had
been conducted. From the scanning results, it was found
7 genes related to cell apoptosis, among them, 4 were
up-regulated and 3 were down-regulated.
Conclusion: The expression of NS4A protein affected the
expression spectrum of 293-CAMLcells, especially some
genes related to cell apoptosis pass way. HCV NS4A maybe
will have some negative effect on the progress of cell
apoptosis, and then lead to the chronic HCV infection.
OL-052 Successful preventive programs in reducing HCV
prevalence and increase blood safety in Abadan
blood donors during 2005 2008
A. Jalali Far Mohammad1, N. Navidpor1, M. Paridar1,
A.H. Ghasemzadeh1, M. Samadi1, J. Torabizadeh maatoghi1,
N. Saki2, S. Negravi3. 1Ahwaz blood transfusion service,
Pasdaran Boulevard, Ahwaz Khouzestan province, Iran;
Iranian Blood Transfusion Organization Research Center,
Iran, 2Hematology Dep. Tarbiat Modares University, Tehran,
Iran, 3Padideh English institute, Iran
Estimated 3% of the world population is infected with
hepatitis C virus and 20% of patients progress to liver
cirrhosis with an increased risk for the development of
hepatocellular carcinoma. In the United States alone, nearly
four million persons are infected and 30,000 acute new
infections are estimated to occur annually. Because the
role of transfusion in HCV transmission and the high number
of blood transfusion dependent patients in Abadan, study of
HCV prevalence in 3 years helps us to evaluating the efﬁcacy
of preventive program in increase the blood safety.
In this descriptive cross sectional survey we studied all
blood donors that referred to Abadan blood center during
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March 2005 until March 2008. The samples tested for HCV-
Ab by using ELISA methods and reactive samples retested
in duplicate manner and repeatedly reactive samples
conﬁrmed by RIBA methods. All data analyzed in SPSS
software.
We found that 1.587%, 0.862% and 0.499% respectively of
blood donors were repeatedly reactive for HCV-Ab. The
conﬁrmatory result in the same period were: 0.311%, 0.314%
and 0.294% respectively. The repeatedly reactive samples
were signiﬁcantly reduced after change the screening kit.
Our ﬁndings showed that HCV prevalence was less than
some of other regions in our country and some neighbor’s
prevalence. Our strategy in reducing HCV prevalence such
as donor selection and educational program was great
effective and meet our goal in enhancing blood safety.
Establishment that strategy for other centers in our province
recommended.
OL-053 Screening and identiﬁcation of genes
trans-regulated by HCV p7 protein with
microarray assay
J. Guo*, J. Cheng, H.C. Xing. Institute of Infectious
Diseases, Beijing Ditan Hospital, Beijing, 100011, China
Introduction: Hepatitis C virus (HCV) is a major cause
of chronic hepatitis, liver cirrhosis, and hepatocellular
carcinoma throughout the world. Although HCV cannot
be incubated efﬁciently in vitro, several of its key
features have been elucidated in the past few years. HCV,
cloned successfully via molecule biological technology, is
an enveloped, positive single-stranded RNA (9.6-kb) virus
belonging to the Flaviviridae. The HCV genome has only one
ORF which is ﬂanked by a 5 and 3 noncoding region. The ORF
encodes for a large polyprotein precursor of about 3 000
amino acid residues, and this precursor protein is cleaved
by the host and viral proteinases to generate at least
10 proteins in the following order: NH2-C-E1-E2-p7-NS2-
NS3-NS4A-NS4B-NS5A-NS5B- COOH. HCV proteins not only
function in viral replication but also affect a variety of
cellular functions. HCV p7, which is located between the
E2 and NS2 proteins, is a 63 residue peptide encoded by
HCV genome between 2 580 2 768 nt. Although there are
studies on the genomic structure, synthesis and function of
p7 protein, the role of the HCV p7 protein in the virus life
cycle is not known. To gain more information on the HCV
p7 protein, and provide some new clues for elucidating the
potential biological function of p7, we use cDNA microarray
technique to screen genes regulated by p7.
Method: To investigate the biological functions of
hepatitis C virus p7, and to use cDNA microarray technique
to screen genes regulated by p7. The HCV p7 coding DNA
fragment was ampliﬁed with polymerase chain reaction
(PCR) technique by using PBRTM plasmid containing the
full length of HCV genome as the template. The expressive
vector of pcDNA3.1-p7 was constructed by routine molecular
biological methods. The HepG2 cells were transfected by
pcDNA3.1( ) and pcDNA3.1-p7, respectively using FuGENE6
transfection Reagent. The total RNA was isolated and re-
verse transcribed. The cDNAs were subjected for microarray
screening with 1152 cDNA probes. The expressive vector
has been constructed and conﬁrmed by restriction enzyme
digestion and DNA sequencing analysis. High quality mRNA
and cDNA had been prepared and successful microarray
screening had been conducted. From the scanning results,
it was found 1 genes were up-regulated and 22 genes were
down-regulated by p7 protein of HCV. HCV p7 protein is a
trans-regulator. The expression of p7 protein affected the
expression spectrum of HCV infected hepatocyte.
Results: See Figures 1 and 2, and table 1.
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Fig. 1. Products of pcDNA3.1( )-p7 PCR and restriction
enzyme cleaved were electrophoresed in 1.0% agarose
gel. Lane 1: EcoRI/BamHI cleaved; M: DNA Marker
(15,000+2,000 bp).
Fig. 2. Structure of expression plasmid pcDNA3.1( )-p7.
Table 1. Trans-regulated genes by HCV p7
Accession
number
Protein Cy3/
Cy5
NM_000553 Werner syndrome (WRN) 0.337
NM_002514 Nephroblastoma overexpressed gene (NOV), mRNA 0.368
AY142112 Anion exchanger SLC4A3 0.394
NM_001122 Adipose differentiation-related protein (ADFP) 0.403
AB028641 SOX11 0.406
NM_002804 Proteasome (prosome, macropain) 26S subunit,
ATPase, 3 (PSMC3)
0.410
AF123320 Lymphocyte activation-associated protein 0.411
NM_015150 Raft-linking protein (RAFTLIN) 0.411
AK131542 Moderately similar to renal tumor antigen 0.405
BC052628 Armadillo repeat containing, X-linked 2 0.419
AB020706 KIAA0899 protein 0.436
NM_015270 Adenylate cyclase 6 (ADCY6) 0.436
NM_005746 Pre-B-cell colony enhancing factor 1 (PBEF1) 0.448
NM_173631 Zinc ﬁnger protein 547 (ZNF547) 0.459
BC046099 TAF15 RNA polymerase II, TATA box binding protein
(TBP)-associated factor
0.473
AF370457 Ovarian epithelial carcinoma-related protein 0.476
NM_015568 PPP1R16B 0.483
NM_003419 ZNF345 0.485
NM_003260 transducin-like enhancer of split 2 (TLE2) 0.492
BC033522 p65 0.481
AK128380 FLJ46523 0.492
BX537378 C21orf4 0.469
NM_183419 RNF19 2.100
